4Dmedical Other Operating Expenses vs Total Revenue Analysis

4DX Stock

0.46 0.01 2.22%

4Dmedical financial indicator trend analysis is way more than just evaluating 4Dmedical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 4Dmedical is a good investment. Please check the relationship between 4Dmedical Other Operating Expenses and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 4Dmedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Other Operating Expenses vs Total Revenue

Other Operating Expenses vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 4Dmedical Other Operating Expenses account and Total Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between 4Dmedical's Other Operating Expenses and Total Revenue is 0.4. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Total Revenue in the same time period over historical financial statements of 4Dmedical, assuming nothing else is changed. The correlation between historical values of 4Dmedical's Other Operating Expenses and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of 4Dmedical are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Other Operating Expenses i.e., 4Dmedical's Other Operating Expenses and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.4

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of 4Dmedical. It is also known as 4Dmedical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Revenue

Total revenue comprises all receipts 4Dmedical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from 4Dmedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 4Dmedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 4Dmedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, 4Dmedical's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 47 M in 2024, whereas Selling General Administrative is likely to drop slightly above 15.5 M in 2024.

	2021	2022	2023	2024 (projected)
Total Revenue	1.1M	282.2K	3.8M	3.9M
Depreciation And Amortization	1.5M	2.6M	4.1M	4.3M

Total Revenue Depreciation And Amortization

4Dmedical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Inventory	Other Current Assets	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Other Liab	Net Tangible Assets	Current Deferred Revenue	Other Assets	Net Receivables	Non Current Liabilities Total	Deferred Long Term Liab
Total Assets		0.84	0.73	0.96	0.9	-0.78	-0.97	0.72	0.79	0.81	-0.41	0.79	0.78	0.67	0.92	0.84	0.81	0.83	1.0	0.99	0.97	0.49	0.81	0.2	0.8	0.88
Other Current Liab	0.84		0.9	0.67	0.84	-0.37	-0.94	0.78	0.43	0.91	-0.14	0.43	0.7	0.74	0.8	0.98	0.46	0.9	0.86	0.89	0.71	0.07	0.71	0.19	0.9	0.78
Total Current Liabilities	0.73	0.9		0.55	0.71	-0.37	-0.82	0.81	0.47	0.7	0.16	0.47	0.79	0.54	0.68	0.92	0.5	0.68	0.73	0.8	0.57	0.14	0.72	0.16	0.68	0.78
Total Stockholder Equity	0.96	0.67	0.55		0.85	-0.9	-0.88	0.64	0.89	0.66	-0.52	0.89	0.73	0.56	0.88	0.66	0.9	0.69	0.95	0.93	1.0	0.64	0.78	0.21	0.65	0.84
Property Plant And Equipment Net	0.9	0.84	0.71	0.85		-0.68	-0.94	0.85	0.71	0.72	-0.36	0.71	0.78	0.57	0.8	0.78	0.74	0.72	0.93	0.89	0.86	0.49	0.83	0.5	0.72	0.9
Net Debt	-0.78	-0.37	-0.37	-0.9	-0.68		0.64	-0.56	-0.99	-0.28	0.48	-0.99	-0.65	-0.28	-0.73	-0.35	-0.98	-0.32	-0.76	-0.74	-0.86	-0.78	-0.72	-0.17	-0.27	-0.73
Retained Earnings	-0.97	-0.94	-0.82	-0.88	-0.94	0.64		-0.82	-0.68	-0.87	0.31	-0.68	-0.8	-0.72	-0.91	-0.92	-0.71	-0.87	-0.98	-0.98	-0.9	-0.34	-0.81	-0.23	-0.86	-0.9
Accounts Payable	0.72	0.78	0.81	0.64	0.85	-0.56	-0.82		0.65	0.5	-0.06	0.65	0.83	0.45	0.72	0.71	0.68	0.48	0.75	0.76	0.62	0.3	0.84	0.33	0.49	0.88
Cash	0.79	0.43	0.47	0.89	0.71	-0.99	-0.68	0.65		0.29	-0.37	1.0	0.74	0.28	0.74	0.41	1.0	0.32	0.77	0.76	0.85	0.79	0.78	0.21	0.27	0.79
Non Current Assets Total	0.81	0.91	0.7	0.66	0.72	-0.28	-0.87	0.5	0.29		-0.29	0.29	0.52	0.77	0.74	0.92	0.33	1.0	0.82	0.82	0.72	0.03	0.54	0.1	1.0	0.62
Non Currrent Assets Other	-0.41	-0.14	0.16	-0.52	-0.36	0.48	0.31	-0.06	-0.37	-0.29		-0.37	0.13	-0.04	-0.33	-0.08	-0.37	-0.33	-0.42	-0.33	-0.54	-0.36	-0.37	-0.21	-0.3	-0.13
Cash And Short Term Investments	0.79	0.43	0.47	0.89	0.71	-0.99	-0.68	0.65	1.0	0.29	-0.37		0.74	0.28	0.74	0.41	1.0	0.32	0.77	0.76	0.85	0.79	0.78	0.21	0.27	0.79
Common Stock Shares Outstanding	0.78	0.7	0.79	0.73	0.78	-0.65	-0.8	0.83	0.74	0.52	0.13	0.74		0.55	0.73	0.71	0.77	0.51	0.77	0.79	0.7	0.49	0.75	0.25	0.5	0.93
Inventory	0.67	0.74	0.54	0.56	0.57	-0.28	-0.72	0.45	0.28	0.77	-0.04	0.28	0.55		0.77	0.72	0.31	0.77	0.68	0.7	0.59	-0.13	0.34	-0.17	0.77	0.52
Other Current Assets	0.92	0.8	0.68	0.88	0.8	-0.73	-0.91	0.72	0.74	0.74	-0.33	0.74	0.73	0.77		0.77	0.76	0.75	0.93	0.95	0.89	0.24	0.67	-0.1	0.73	0.79
Total Liab	0.84	0.98	0.92	0.66	0.78	-0.35	-0.92	0.71	0.41	0.92	-0.08	0.41	0.71	0.72	0.77		0.44	0.91	0.84	0.88	0.7	0.09	0.68	0.15	0.91	0.76
Total Current Assets	0.81	0.46	0.5	0.9	0.74	-0.98	-0.71	0.68	1.0	0.33	-0.37	1.0	0.77	0.31	0.76	0.44		0.35	0.8	0.79	0.86	0.77	0.8	0.23	0.31	0.82
Intangible Assets	0.83	0.9	0.68	0.69	0.72	-0.32	-0.87	0.48	0.32	1.0	-0.33	0.32	0.51	0.77	0.75	0.91	0.35		0.83	0.83	0.75	0.06	0.55	0.09	1.0	0.62
Common Stock	1.0	0.86	0.73	0.95	0.93	-0.76	-0.98	0.75	0.77	0.82	-0.42	0.77	0.77	0.68	0.93	0.84	0.8	0.83		0.99	0.97	0.46	0.81	0.23	0.81	0.88
Other Liab	0.99	0.89	0.8	0.93	0.89	-0.74	-0.98	0.76	0.76	0.82	-0.33	0.76	0.79	0.7	0.95	0.88	0.79	0.83	0.99		0.94	0.4	0.81	0.13	0.81	0.89
Net Tangible Assets	0.97	0.71	0.57	1.0	0.86	-0.86	-0.9	0.62	0.85	0.72	-0.54	0.85	0.7	0.59	0.89	0.7	0.86	0.75	0.97	0.94		0.59	0.77	0.2	0.71	0.82
Current Deferred Revenue	0.49	0.07	0.14	0.64	0.49	-0.78	-0.34	0.3	0.79	0.03	-0.36	0.79	0.49	-0.13	0.24	0.09	0.77	0.06	0.46	0.4	0.59		0.59	0.59	0.02	0.54
Other Assets	0.81	0.71	0.72	0.78	0.83	-0.72	-0.81	0.84	0.78	0.54	-0.37	0.78	0.75	0.34	0.67	0.68	0.8	0.55	0.81	0.81	0.77	0.59		0.44	0.52	0.86
Net Receivables	0.2	0.19	0.16	0.21	0.5	-0.17	-0.23	0.33	0.21	0.1	-0.21	0.21	0.25	-0.17	-0.1	0.15	0.23	0.09	0.23	0.13	0.2	0.59	0.44		0.11	0.33
Non Current Liabilities Total	0.8	0.9	0.68	0.65	0.72	-0.27	-0.86	0.49	0.27	1.0	-0.3	0.27	0.5	0.77	0.73	0.91	0.31	1.0	0.81	0.81	0.71	0.02	0.52	0.11		0.61
Deferred Long Term Liab	0.88	0.78	0.78	0.84	0.9	-0.73	-0.9	0.88	0.79	0.62	-0.13	0.79	0.93	0.52	0.79	0.76	0.82	0.62	0.88	0.89	0.82	0.54	0.86	0.33	0.61

Click cells to compare fundamentals

4Dmedical Account Relationship Matchups

4Dmedical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	15.8M	92.6M	74.3M	92.9M	120.0M	126.0M
Other Current Liab	9.0M	969.8K	6.6M	11.6M	18.5M	19.4M
Total Current Liabilities	27.0M	8.2M	9.6M	17.1M	21.9M	23.0M
Total Stockholder Equity	(11.8M)	83.4M	59.5M	71.5M	70.9M	74.5M
Property Plant And Equipment Net	1.8M	2.8M	10.4M	9.3M	8.7M	9.2M
Net Debt	8.1M	(79.2M)	(44.9M)	(64.4M)	(25.5M)	(26.8M)
Retained Earnings	(38.6M)	(60.0M)	(84.6M)	(116.1M)	(152.0M)	(144.4M)
Accounts Payable	1.7M	448.2K	1.8M	2.9M	2.1M	1.1M
Cash	8.4M	80.9M	51.1M	69.6M	30.6M	27.1M
Non Current Assets Total	5.5M	6.8M	15.5M	14.4M	81.0M	85.0M
Non Currrent Assets Other	2.9M	3.8M	84.2K	44.8K	40.3K	38.3K
Cash And Short Term Investments	8.4M	80.9M	51.1M	69.6M	30.6M	27.1M
Common Stock Shares Outstanding	264.8M	261.4M	294.5M	300.0M	327.1M	209.4M
Liabilities And Stockholders Equity	15.8M	92.6M	74.3M	92.9M	120.0M	126.0M
Inventory	16.0K	153.4K	1.5K	665.0K	992.2K	1.0M
Other Current Assets	489.0K	4.4M	1.4M	7.5M	6.2M	6.5M
Total Liab	27.6M	9.3M	14.8M	21.5M	49.1M	51.5M
Total Current Assets	10.3M	85.8M	58.9M	78.5M	39.1M	31.3M
Intangible Assets	512.9K	3.9M	5.1M	5.1M	29.5M	30.9M
Common Stock	18.9M	141.6M	141.7M	184.4M	218.4M	229.4M
Other Stockholder Equity	7.8M	1.8M	2.4M	3.2M	3.6M	2.7M
Accumulated Other Comprehensive Income	7.8M	1.8M	2.4M	3.2M	4.5M	3.3M
Other Liab	55.3K	146.6K	104.6K	185.8K	213.7K	224.3K
Net Tangible Assets	(12.3M)	82.7M	58.5M	70.4M	81.0M	85.1M
Current Deferred Revenue	523.6K	6.0M	6.4M	1.7M	1.0M	957.0K
Other Assets	2.9M	3.3M	4.1M	4.1M	4.7M	2.5M
Net Receivables	1.8M	426.6K	6.4M	815.0K	1.3M	1.7M
Long Term Debt Total	621.2K	965.4K	5.1M	4.2M	4.8M	5.1M
Non Current Liabilities Total	676.4K	1.1M	5.2M	4.4M	27.2M	28.6M
Deferred Long Term Liab	2.7M	3.3M	4.1M	4.1M	4.7M	3.0M
Short Term Debt	16.2M	723.5K	1.1M	933.1K	944.6K	897.4K
Property Plant Equipment	1.8M	2.8M	10.4M	9.3M	10.6M	11.2M
Short Long Term Debt Total	16.5M	1.7M	6.2M	5.1M	5.1M	6.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for 4Dmedical Stock Analysis

When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC